Physician profile
Jonathan D Allred
NPI 1134185127
$1,382.27
in general payments reported to CMS, 2019-2025
17 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.94 · 2020: $20.80 · 2024: $207 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $313.54 | 2020-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $207.81 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $153.58 | 2024-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $77.25 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Eisai INC. | $74.24 | 2025 | |
| Astellas Pharma US INC | $73.72 | 2025 | Veozah |
| Abbvie INC. | $70.87 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.89 | 2024-2025 | Caplyta |
| Esperion Therapeutics, INC. | $52.72 | 2024-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $52.67 | 2025 | |
| Inspire Medical Systems, INC. | $47.00 | 2025 | Inspire |
| Xeris Pharmaceuticals, INC. | $42.59 | 2025 | Gvoke Hypopen |
| Pfizer INC. | $39.82 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.20 | 2025 | Jardiance |
| Exact Sciences Corporation | $32.05 | 2024-2025 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $30.02 | 2025 | Neffy |
| Bayer Healthcare Pharmaceuticals INC. | $17.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.